Legend Biotech Corp. (LEGN) PT Lowered to $78 at Barclays
Tweet
Share
E-mailGet Alerts LEGN Hot Sheet
Price: $20.76 -3.53%
Rating Summary:
16 Buy, 7 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 25 | Down: 23 | New: 33
Rating Summary:
16 Buy, 7 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 25 | Down: 23 | New: 33
Join SI Premium – FREE
Barclays analyst Gena Wang lowered the price target on Legend Biotech Corp. (NASDAQ: LEGN) to $78.00 (from $80.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Quest Diagnostics (DGX) PT Raised to $245 at UBS
- Roivant Sciences (ROIV) PT Raised to $52 at Jefferies
- Pharvaris B.V. (PHVS) PT Raised to $65 at Cantor Fitzgerald
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
